Brexit-related guidance for companies: update
17 juin 2019
The European Council agreed to a further extension (under Article 50) of the date for the UK’s withdrawal from the EU at its meeting on 10-11 April. The extension will last as long as necessary and, in any event, no longer than 31 October 2019.
The UK remains a Member State for the duration of the extension.
EMA calls on all pharmaceutical companies in the EU to continue their preparedness for the UK’s withdrawal.
Based on the European Council decision, and until further notice, the deadline of 29 March 2019 referred to in Brexit related guidance should be understood as referring to 31 October 2019.
Vous avez aimé cet article ? Partagez le sur les réseaux sociaux :